LyGenesis
A clinical-stage cell therapy company that transforms a patient's lymph nodes into bioreactors capable of growing functioning ectopic organs.
Launch date
Employees
Market cap
-
Enterprise valuation
$76—114m (Dealroom.co estimates Oct 2023.)
Pittsburgh Pennsylvania (HQ)
Authorizing premium user...